Sign in
Taking people in United StatesNo phase

Follows people with sarcoma over time after diagnosis and treatment

Studies how sarcoma and its treatment affect patients over their lifetime.

Key facts

Who runs it
Vanderbilt-Ingram Cancer Center
Where
Nashville, United StatesSee the site
Trial code
Registry title
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Status
Recruiting
People taking part
2,100 people, planned
Started
1 Apr 2022
Expected to end
Apr 2029
Type of study
Observational
Treatments tested
  • Surveys
  • Blood Collection
  • Saliva Collection
  • Urine Collection
  • Stool Collection
  • Tissue collection
  • Physical Activity Monitoring
Record updated
19 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people of any age who have ever had sarcoma, whether or not the disease is still present. For children, a parent or main caregiver and siblings aged 8 or older can also join.

Age
Any age. Siblings of child patients must be 8 years or older.
Sex
All sexes can join.
Disease stage
A history of sarcoma, with or without evidence of persistent disease.

The registry criteria, word for word

Show all 4 criteriaShow less

Other criteria

  • Patients at any age with a history of sarcoma, with or without evidence of a persistent disease
  • For pediatric patients
  • Parent/primary caregiver of patient
  • Sibling of patient aged 8 years or older

Where in United States

  • Vanderbilt University/Ingram Cancer CenterNashville, United StatesContact: Vanderbilt-Ingram Service for Timely AccessTaking people

About the trial

What the trial wants to find out

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

The group in the trial

  • Observational

    Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.

    Treatment: Surveys, Blood Collection, Saliva Collection, Urine Collection, Stool Collection, Tissue collection, and Physical Activity Monitoring

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Plain-language title
Follows people with sarcoma over time after diagnosis and treatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
19 September 2025